[New post] NIH Notices

L&D Associates Grant Blog posted: " Policy Notices AHRQ Announces Interest in Research on Digital Healthcare Safety(NOT-HS-22-004)Agency for Healthcare Research and QualityReminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 202" Respond to this post by replying above this line New post on L&D Associates' Grant News NIH Notices by L&D Associates Grant Blog Policy Notices AHRQ Announces Interest in Research on Digital Healthcare Safety (NOT-HS-22-004) Agency for Healthcare Research and Quality Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available (NOT-OD-22-018) National Institutes of Health Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities (NOT-OD-22-019) National Institutes of Health General Notices Notice to Rescind NOT-DC-21-006, "Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission" (NOT-DC-22-003) National Institute on Deafness and Other Communication Disorders Notice to rescind NOT-DC-22-002, "Notice of Informational Webinar for PAR-21-063 and PAR-21-064: Planning to Consult with the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN)" (NOT-DC-22-004) National Institute on Deafness and Other Communication Disorders Notice of Informational Webinar for RFA-NS-22-002 "HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required)" (NOT-NS-22-033) National Institute of Neurological Disorders and Stroke Guidance electronic Research Administration (eRA) Research Performance Progress Report (RPPR) Submission Validations for Clinical Trial Registration and Results Reporting (NOT-OD-22-008) National Institutes of Health Notice of Participation of OBSSR in PAR-21-271 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (NOT-OD-22-013) Office of Behavioral and Social Sciences Research Notice of Participation of OBSSR in PAR-21-272 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) (NOT-OD-22-014) Office of Behavioral and Social Sciences Research Notice of Participation of the Office of Behavioral and Social Sciences Research (OBSSR) in PAR-21-273 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - (NOT-OD-22-015) Office of Behavioral and Social Sciences Research Request for Information (RFI): Joint Pain and Innervation Research (NOT-AR-22-008) National Institute of Arthritis and Musculoskeletal and Skin Diseases National Center for Complementary and Integrative Health National Institute of Biomedical Imaging and Bioengineering National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Request for Information (RFI): Seeking Input on Technology Needs for Cancer Control and Population Sciences Researchers (NOT-CA-22-004) National Cancer Institute Notice of Changes to Funding Opportunities Notice of Change to Funding Opportunity Purpose for PAR-20-317 "NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)" (NOT-AG-21-063) National Institute on Aging Notice of Change to Key Dates Section of PAR-21-351, NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) (NOT-AG-21-064) National Institute on Aging Notice of Correction to NOT-CA-21-101, "Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules (NOT-CA-22-006) National Cancer Institute Notice to Extend Expiration Date for PAR-19-145 "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03) (NOT-DE-21-017) National Institute of Dental and Craniofacial Research Notice of Change in the Application Due Date for NOT-GM-21-051 "Notice of Special Interest (NOSI): Program Priority Areas for MOSAIC UE5 - November 2021 Application Due Date" (NOT-GM-22-002) National Institute of General Medical Sciences Notice of Change in the 2021 Application Due Date for PAR-21-277 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity" (NOT-GM-22-003) National Institute of General Medical Sciences Notice of Early Expiration of NOT-HL-19-712, "Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health" (NOT-HL-21-036) National Heart, Lung, and Blood Institute Notice of NHLBI Participation in NOT-AT-21-002 "Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease (R01) (NOT-HL-21-037) National Heart, Lung, and Blood Institute Notice of NHLBI Participation in RFA-NS-21-010: "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)" (NOT-HL-21-039) National Heart, Lung, and Blood Institute Notice of NHLBI Participation in RFA-NS-21-015: "HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)" (NOT-HL-21-040) National Heart, Lung, and Blood Institute Notice of NHLBI Participation in RFA-NS-21-029: "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)" (NOT-HL-21-041) National Heart, Lung, and Blood Institute Notice of Extension of PAR-19-189, "Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)" (NOT-MH-22-035) National Institute of Mental Health Notice to Clarify Award Budget for RFA-NS-22-009 "Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)" (NOT-NS-22-038) National Institute of Neurological Disorders and Stroke Notice of Change to the Required Tables in PAR-21-336, Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards for the Clinical and Translational Science Awards (CTSA) Program (NOT-TR-22-006) National Center for Advancing Translational Sciences Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed) (NOT-NS-22-034) National Institute of Neurological Disorders and Stroke Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) (NOT-NS-22-035) National Institute of Neurological Disorders and Stroke Notice of Intent to Publish a Funding Opportunity Announcement for Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection - Interventions (U01 CT Not Allowed) (NOT-NS-22-036) National Institute of Neurological Disorders and Stroke Notice of Intent to Publish a Funding Opportunity Announcement for Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Interventions from Small Businesses (U44 CT Not Allowed) (NOT-NS-22-037) National Institute of Neurological Disorders and Stroke Notices of Special Interest Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician-Scientist Award in Alzheimers Disease and Related Dementias (AD/ADRD) (NOT-AG-21-054) National Institute on Aging Notice of Special Interest (NOSI): Clinical Characterization and Intervention Strategies for Cancer Therapy Induced Adverse Sequelae (NOT-CA-22-005) National Cancer Institute Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (NOT-HL-22-001) National Heart, Lung, and Blood Institute Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) (NOT-MD-22-001) National Institute on Minority Health and Health Disparities National Institute on Drug Abuse This free site is ad-supported. Learn more ​ L&D Associates Grant Blog | November 1, 2021 at 2:47 am | URL: https://wp.me/p1lvk-4MP Comment    See all comments    Like Unsubscribe to no longer receive posts from L&D Associates' Grant News. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://landdgrantblog.wordpress.com/2021/11/01/nih-notices-231/ Thanks for flying with WordPress.com